Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 21,120 shares at $59.03 ($1.2M) on 2026-04-14, disclosed to the SEC on 2026-04-16.
Scheduled sale ($1.2M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.03 | 6,548 | $387K | 32.2% |
| 2 | $59.69 | 492 | $29K | 2.4% |
| 3 | $56.27 | 2,623 | $148K | 12.3% |
| 4 | $57.21 | 3,618 | $207K | 17.2% |
| 5 | $58.11 | 799 | $46K | 3.9% |
| 6 | $54.56 | 5,190 |
| $283K |
| 23.6% |
| 7 | $54.88 | 1,850 | $102K | 8.4% |
| Total | $56.89 avg | 21,120 | $1.2M | 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |
| PAHC | SELL | 2026-03-26 | $2.3M | — | Filing → |